Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTNT.L Regulatory News (TNT)

  • There is currently no data for TNT

Update on Proxy Votes Re: Special Resolutions

27 Dec 2023 07:00

RNS Number : 8425X
Tintra PLC
27 December 2023
 

 THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF REGULATION 11 OF THE MARKET ABUSE (AMENDMENT) (EU EXIT) REGULATIONS 2019/310.

 

27 December 2023

 

Tintra plc

("Tintra", the "Group" or the "Company")

 

Proxy votes relating to Special Resolutions

 

 

On 6 December 2023, Tintra, the Deep Tech & Banking business, notified shareholders of a General Meeting to seek shareholder approval for the cancellation of admission to trading of the Shares on AIM and the re-registration of the Company as a private limited company (the "Resolutions"). The Company is pleased to update the market on the current status of voting.

 

As at close of business on 21 December 2023, the Company had received proxy votes directly or through nominees, relating to 10,925,340 Shares ("Proxy Votes Received"). All of the Proxy Votes Received are in favour of the Resolutions and represent 61.63% of the total ordinary shares in issue of 17,727,953. As of this date no proxy votes against either resolution had been received directly by the Company or by the Company's Registrar.

 

The deadline for the Company to receive proxy votes is 48 hours before the General Meeting. As such the Company will provide a further update of proxy votes received on 4 January 2024.

 

Any shareholder wishing to confirm that their vote has been registered should contact the Company via its Company Secretary.

 

For further information, contact:

 

Tintra PLC

Company Secretary

a.flitcroft@tintra.com

Website www.tintra.com

 

Communications Head

Hannah Haffield

h.haffield@tintra.com

Website www.tintra.com

 

020 3795 0421

 

 

 

 

020 3795 0421

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
STRKXLBLXLLFFBD
Date   Source Headline
2nd Jun 20237:00 amRNSTotal Voting Rights & Licence Update
25th May 20232:17 pmRNSUpdate on UK Licence Application
23rd May 20239:38 amRNSReplacement - Director/PDMR Shareholding
16th May 20232:00 pmRNSNew Patent Applications
5th May 202312:32 pmRNSUpdate in relation to the Placement Facility
4th May 20237:00 amRNSConversion of Loan Stock and Total Voting Rights
6th Apr 20231:08 pmRNSRepayment Under Placement Facility
31st Mar 20235:00 pmRNSTotal Voting Rights
31st Mar 202311:55 amRNSParticipation in the Call to Advance Democracy
30th Mar 20233:00 pmRNSDirector/PDMR Shareholding
17th Mar 20232:15 pmRNSDirector/PDMR Shareholding
13th Mar 20233:07 pmRNSNotification of US Patent to Protect Web3 IP
10th Mar 202310:30 amRNSStrategic investment under current funding round
9th Mar 20237:00 amRNSKey Management Appointment & Directorate Change
8th Mar 20239:30 amRNSTintra to establish new hub in Rwanda
3rd Feb 20237:00 amRNSKey Management Appointment
2nd Feb 202311:00 amRNSUpdate on US Patent Applications
30th Jan 20237:45 amRNSIssue of Ordinary Shares Under Funding Round
25th Jan 20237:00 amRNSAppointment of Chief Operating Officer
16th Jan 20234:40 pmRNSSecond Price Monitoring Extn
16th Jan 20234:35 pmRNSPrice Monitoring Extension
3rd Jan 20237:00 amRNSTotal Voting Rights
21st Dec 20221:00 pmRNSHolding(s) in Company
16th Dec 20227:30 amRNSUS$10,000,000 Placement Facility
16th Dec 20227:00 amRNSStrategic Investment Under Current Funding Round
30th Nov 20223:31 pmRNSUpdate on Funding Round
8th Nov 20229:00 amRNSIssue of Convertible Loan Notes & PCA Holding
8th Nov 20227:30 amRNSBusiness Update
27th Oct 20227:00 amRNSHalf-year Report to 31 July 2022
18th Oct 202212:00 pmRNSUpdate on PPS Asset Realisation Co Limited
4th Oct 202212:00 pmRNSTotal Voting Rights
27th Sep 20227:00 amRNSUpdate on PPS Asset Realisation Co Limited
22nd Sep 20227:00 amRNSAppointment of Chief Innovation Officer
21st Sep 20226:00 pmRNSExercise of Options & Conversion Rights
21st Sep 202211:05 amRNSResult of Adjourned AGM
14th Sep 202210:30 amRNSGranting of Middle East Licence
14th Sep 20227:00 amRNSContract with Temenos for Core Banking Software
24th Aug 202210:30 amRNSNotice of Reconvening of AGM & Supplementary Note
1st Aug 20227:00 amRNSFinal Results & Annual Report for Yr to 31 Jan 22
29th Jul 202210:36 amRNSResult of AGM
29th Jul 20227:00 amRNSAGM Statement
11th Jul 20222:00 pmRNSUS Patent Application Filings to Protect Web3 IP
7th Jul 20227:00 amRNSFiling of UK Patent Application & Notice of AGM
28th Jun 20227:00 amRNSAI in banking needs to be 'explainable'
27th Jun 20227:00 amRNSAppointment of Chief Science Officer
16th Jun 20227:00 amRNSPatent Application
15th Jun 20227:00 amRNSWestern banks prefer metaverse to emerging markets
8th Jun 20227:00 amRNSThe importance of financial inclusion
20th May 20227:00 amRNSBusiness Update
29th Apr 20225:30 pmRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.